Corneal cytotoxicity of topically applied drugs, vehicles and preservatives
- PMID: 6998034
- DOI: 10.1016/0039-6257(80)90072-7
Corneal cytotoxicity of topically applied drugs, vehicles and preservatives
Abstract
The toxicity and side effects of drugs and their adjuncts are reviewed according to effect on corneal epithelium, stroma, and endothelium, when topically applied to healthy or wounded surfaces, or introduced into the anterior chamber of the eye. Corneal research techniques are reviewed, including scanning and transmission electron microscopy, electrophysiological techniques, and specular microscope observation. Clinical interpretation of these results is discussed. Reviews of specific toxicologic techniques and of medications are cited. Present research makes it increasingly apparent that not only medications but also their preservatives cannot be considered innocuous. Preservatives may be effective yet less damaging to the ocular integument when used at lower concentrations than those presently available commercially. Complete avoidance of preservatives by the use of special dispensing systems is found increasingly desirable.
Similar articles
-
PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE.Rom J Ophthalmol. 2015 Jan-Mar;59(1):2-5. Rom J Ophthalmol. 2015. PMID: 27373107 Free PMC article. Review.
-
Problems with unpreserved lignocaine for intraocular use.J Cataract Refract Surg. 2000 May;26(5):633. doi: 10.1016/s0886-3350(00)00462-4. J Cataract Refract Surg. 2000. PMID: 10850922 No abstract available.
-
[Ultrastructural and experimental study of the ocular toxicity of antibiotics and antifungals on the corneal endothelium (author's transl)].J Fr Ophtalmol. 1981;4(3):205-12. J Fr Ophtalmol. 1981. PMID: 7264208 French.
-
The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review.Curr Opin Ophthalmol. 2007 Mar;18(2):134-9. doi: 10.1097/ICU.0b013e328089f1c8. Curr Opin Ophthalmol. 2007. PMID: 17301615 Review.
-
Sensitive and real-time method for evaluating corneal barrier considering tear flow.Biol Pharm Bull. 2010;33(1):107-10. doi: 10.1248/bpb.33.107. Biol Pharm Bull. 2010. PMID: 20045945
Cited by
-
Cytotoxicity of five fluoroquinolone and two nonsteroidal anti-inflammatory benzalkonium chloride-free ophthalmic solutions in four corneoconjunctival cell lines.Clin Ophthalmol. 2010 Sep 20;4:1019-24. doi: 10.2147/opth.s12452. Clin Ophthalmol. 2010. PMID: 20922036 Free PMC article.
-
Efficacy of treatments for neurotrophic keratopathy: a systematic review and meta-analysis.Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2623-2637. doi: 10.1007/s00417-022-05602-z. Epub 2022 Mar 7. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35254511
-
Control of microbial contamination in unpreserved eyedrops.Br J Ophthalmol. 1996 Jul;80(7):588-91. doi: 10.1136/bjo.80.7.588. Br J Ophthalmol. 1996. PMID: 8795368 Free PMC article.
-
Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study.Adv Ther. 2015 Sep;32(9):823-37. doi: 10.1007/s12325-015-0246-9. Epub 2015 Sep 30. Adv Ther. 2015. PMID: 26424331 Free PMC article. Clinical Trial.
-
Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial.Graefes Arch Clin Exp Ophthalmol. 2010 Dec;248(12):1757-64. doi: 10.1007/s00417-010-1397-7. Epub 2010 May 2. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 20437244 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical